Bone marrow dosimetry for radioimmunotherapy: theoretical considerations

Area of Science:

• Nuclear medicine
• Medical physics
• Hematology

Background:

• Red marrow is the dose-limiting organ in radioimmunotherapy.
• Accurate radioactivity concentration estimates in red marrow are crucial for dosimetry.
• Current estimation methods rely on blood sampling or bone marrow biopsy, which have limitations.

Purpose of the Study:

• To develop a simple equation for calculating the red marrow-to-blood activity concentration ratio.
• To provide equations for correcting bone marrow biopsy activity concentration for contamination.
• To improve the accuracy of red marrow dosimetry in radioimmunotherapy.

Main Methods:

• Developed a predictive equation for the red marrow-to-blood activity concentration ratio using hematocrit and red marrow extracellular fluid fraction.
• Derived equations to correct bone marrow biopsy samples for bone, yellow marrow, and blood contamination.
• Validated the predicted ratio against experimental data.

Main Results:

• The predicted red marrow-to-blood activity concentration ratio is 0.36, assuming a hematocrit of 0.47 and red marrow extracellular fluid fraction of 0.19.
• This ratio is consistent with experimental findings.
• Bone marrow biopsy activity concentration can be underestimated by 1.5-5 times without corrections.
• A correction factor of 2.73 for an average biopsy and 1.92 for a sample with cortical bone removed was determined.

Conclusions:

• The developed equations provide a simple and accurate method for estimating red marrow activity concentration.
• These methods can significantly improve the accuracy of red marrow dosimetry in radioimmunotherapy.
• Correcting bone marrow biopsy data is essential to avoid underestimation of red marrow activity concentration.